Währungen / ANIP
ANIP: ANI Pharmaceuticals Inc
93.50
USD
0.97
(1.05%)
Der Wechselkurs von ANIP hat sich für heute um 1.05% verändert. Im Laufe des Tages wurde das Instrument von einem Tief von 91.97 bis zu einem Hoch von 93.72 gehandelt.
Verfolgen Sie die ANI Pharmaceuticals Inc-Dynamik. Mit Echtzeit-Kursen können Sie schnell auf Marktveränderungen reagieren. Indem Sie zwischen verschiedenen Zeitrahmen wechseln, können Sie Kurstrends und -dynamik nach Minuten, Stunden, Tagen, Wochen und Monaten verfolgen. Nutzen Sie diese Informationen, um Marktveränderungen vorherzusagen und fundierte Handelsentscheidungen zu treffen.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
ANIP News
- J&J Ends Imaavy Development in Rheumatoid Arthritis Post Study Failure
- Ani Pharmaceuticals stock hits 52-week high at 93.0 USD
- Adaptive Biotechnologies Corporation (ADPT) Hits Fresh High: Is There Still Room to Run?
- ANI Pharmaceuticals (ANIP) is a Great Momentum Stock: Should You Buy?
- IOVA Stock Drops 6% on $350M Common Stock Offering
- Is ANI (ANIP) a Solid Growth Stock? 3 Reasons to Think "Yes"
- GILD Stock Slips as CVS Health Excludes New HIV Drug Yeztugo
- Is Amarin (AMRN) Stock Outpacing Its Medical Peers This Year?
- ANI Pharmaceuticals, Inc. (ANIP) Hits Fresh High: Is There Still Room to Run?
- Ani Pharmaceuticals stock hits 52-week high at 90.43 USD
- Axon, DoorDash, Harmony Gold Among Today's Best Stocks To Buy And Watch: Check Out New Names Added To IBD Stock Lists
- ANI Pharmaceuticals stock price target raised to $77 from $65 at Truist Securities
- ANI (ANIP) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
- ANI Pharmaceuticals stock price target raised to $93 from $84 at H.C. Wainwright
- ANI Pharmaceuticals stock price target raised to $93 from $84 at H.C. Wainwright
- Ani Pharmaceuticals stock hits 52-week high at 77.86 USD
- ANI Pharma earnings beat by $0.40, revenue topped estimates
- ANI Pharmaceuticals (ANIP) Q2 Earnings and Revenues Surpass Estimates
- Sutro Biopharma, Inc. (STRO) Reports Q2 Loss, Beats Revenue Estimates
- Constellation Software, Under Armour, Muenchener Rueckver set to report Friday
- How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
- Kymera Therapeutics, Inc. (KYMR) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
- CG Oncology wins Delaware jury trial against ANI Pharmaceuticals
- ANI Pharmaceuticals (ANIP) Earnings Expected to Grow: What to Know Ahead of Q2 Release
Tagesspanne
91.97
93.72
Jahresspanne
52.50
93.72
- Vorheriger Schlusskurs
- 92.53
- Eröffnung
- 93.03
- Bid
- 93.50
- Ask
- 93.80
- Tief
- 91.97
- Hoch
- 93.72
- Volumen
- 705
- Tagesänderung
- 1.05%
- Monatsänderung
- 48.13%
- 6-Monatsänderung
- 53.88%
- Jahresänderung
- 48.60%
30 August, Samstag